Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 15, 2019

Primary Completion Date

October 15, 2021

Study Completion Date

March 31, 2022

Conditions
Diabetes MellitusMicrovascular Coronary Artery Disease
Interventions
DRUG

Ticagrelor

ticagrelor 60 mg BID for 30 days

DRUG

Clopidogrel

clopidogrel 75mg OD for 30 Days

Sponsors
All Listed Sponsors
collaborator

IHF GmbH - Institut für Herzinfarktforschung

OTHER

collaborator

Hippocrates Research

OTHER

collaborator

IRW consulting AB

UNKNOWN

collaborator

AstraZeneca

INDUSTRY

lead

Region Skane

OTHER